Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Julphar
Fuji
Cerilliant
US Department of Justice
Harvard Business School
Covington
Teva

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,174,442

« Back to Dashboard

Which drugs does patent 6,174,442 protect, and when does it expire?

Patent 6,174,442 protects VELPHORO and is included in one NDA.

This patent has twenty-two patent family members in twenty countries.
Summary for Patent: 6,174,442
Title: Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent
Abstract:An adsorbent for phosphate from aqueous medium, particularly for inorganic phosphate or phosphate bound to foodstuffs from body fluids or foodstuffs, which contains beta-iron hydroxide stabilized by carbohydrates and/or by humic acid.
Inventor(s): Geisser; Peter (St. Gallen, CH), Philipp; Erik (St. Gallen, CH)
Assignee: Vifor (International) AG (St. Gallen, SE)
Application Number:09/077,944
Patent Claim Types:
see list of patent claims
Compound; Process; Formulation;

Drugs Protected by US Patent 6,174,442

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Vifor Fresenius VELPHORO sucroferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y CONTROL OF PHOSPHOROUS LEVELS IN PATIENTS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,174,442

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany195 47 356Dec 19, 1995
PCT Information
PCT FiledDecember 19, 1996PCT Application Number:PCT/EP96/05695
PCT Publication Date:June 26, 1997PCT Publication Number: WO97/22266

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
AstraZeneca
Colorcon
Fuji
Cipla
Chubb
Merck
Queensland Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.